193 related articles for article (PubMed ID: 26335059)
1. Cerebral glucose metabolism in adults with neurofibromatosis type 1.
Apostolova I; Derlin T; Salamon J; Amthauer H; Granström S; Brenner W; Mautner VF; Buchert R
Brain Res; 2015 Nov; 1625():97-101. PubMed ID: 26335059
[TBL] [Abstract][Full Text] [Related]
2. Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1.
Buchert R; von Borczyskowski D; Wilke F; Gronowsky M; Friedrich RE; Brenner W; Mester J; Clausen M; Mautner VF
Nucl Med Commun; 2008 Jan; 29(1):17-26. PubMed ID: 18049093
[TBL] [Abstract][Full Text] [Related]
3. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
[TBL] [Abstract][Full Text] [Related]
4. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.
Kim IJ; Kim SJ; Kim YK
Acta Radiol; 2009 Dec; 50(10):1169-74. PubMed ID: 19922315
[TBL] [Abstract][Full Text] [Related]
5. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
[TBL] [Abstract][Full Text] [Related]
6. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T
J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509
[TBL] [Abstract][Full Text] [Related]
7. Voxel-based analysis of normal cerebral [18F]FDG uptake during childhood using statistical parametric mapping.
London K; Howman-Giles R
Neuroimage; 2015 Feb; 106():264-71. PubMed ID: 25481795
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Chirindel A; Chaudhry M; Blakeley JO; Wahl R
J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
[TBL] [Abstract][Full Text] [Related]
9. Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury.
Zhang J; Mitsis EM; Chu K; Newmark RE; Hazlett EA; Buchsbaum MS
J Neurotrauma; 2010 Jan; 27(1):35-49. PubMed ID: 19715400
[TBL] [Abstract][Full Text] [Related]
10. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
[TBL] [Abstract][Full Text] [Related]
11. A voxel-based analysis of FDG-PET in traumatic brain injury: regional metabolism and relationship between the thalamus and cortical areas.
García-Panach J; Lull N; Lull JJ; Ferri J; Martínez C; Sopena P; Robles M; Chirivella J; Noé E
J Neurotrauma; 2011 Sep; 28(9):1707-17. PubMed ID: 21770759
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography in children with neurofibromatosis-1.
Kaplan AM; Chen K; Lawson MA; Wodrich DL; Bonstelle CT; Reiman EM
J Child Neurol; 1997 Nov; 12(8):499-506. PubMed ID: 9430315
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
[TBL] [Abstract][Full Text] [Related]
14. Value of PET in the assessment of patients with neurofibromatosis type 1.
Bredella MA; Torriani M; Hornicek F; Ouellette HA; Plamer WE; Williams Z; Fischman AJ; Plotkin SR
AJR Am J Roentgenol; 2007 Oct; 189(4):928-35. PubMed ID: 17885067
[TBL] [Abstract][Full Text] [Related]
15. Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary study.
Song SH; Kim IJ; Kim SJ; Kwak IS; Kim YK
Psychiatry Clin Neurosci; 2008 Oct; 62(5):554-61. PubMed ID: 18950375
[TBL] [Abstract][Full Text] [Related]
16. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
[TBL] [Abstract][Full Text] [Related]
17. Thalamic abnormalities in children with continuous spike-wave during slow-wave sleep: An F-18-fluorodeoxyglucose positron emission tomography perspective.
Agarwal R; Kumar A; Tiwari VN; Chugani H
Epilepsia; 2016 Feb; 57(2):263-71. PubMed ID: 26697846
[TBL] [Abstract][Full Text] [Related]
18. Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor.
Ha SW; Yang YS; Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2015 Apr; 56(4):482-6. PubMed ID: 24782572
[TBL] [Abstract][Full Text] [Related]
19. Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.
Apostolova I; Niedzielska D; Derlin T; Koziolek EJ; Amthauer H; Salmen B; Pahnke J; Brenner W; Mautner VF; Buchert R
J Cereb Blood Flow Metab; 2015 Aug; 35(8):1304-12. PubMed ID: 25785829
[TBL] [Abstract][Full Text] [Related]
20. Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
Kim HW; Oh M; Oh JS; Oh SJ; Lee SJ; Chung SJ; Kim JS
PLoS One; 2017; 12(1):e0169928. PubMed ID: 28085923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
